KLP Kapitalforvaltning AS Buys 2,800 Shares of Oscar Health, Inc. $OSCR

KLP Kapitalforvaltning AS raised its stake in Oscar Health, Inc. (NYSE:OSCR) by 8.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 36,700 shares of the company’s stock after acquiring an additional 2,800 shares during the quarter. KLP Kapitalforvaltning AS’s holdings in Oscar Health were worth $787,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. Belpointe Asset Management LLC bought a new position in Oscar Health in the 2nd quarter valued at about $690,000. Fortis Capital Advisors LLC bought a new position in Oscar Health in the 2nd quarter valued at about $690,000. Ameritas Advisory Services LLC bought a new position in shares of Oscar Health during the second quarter worth approximately $93,000. Matauro LLC bought a new position in shares of Oscar Health during the second quarter worth approximately $1,508,000. Finally, Bosman Wealth Management LLC bought a new position in shares of Oscar Health during the second quarter worth approximately $1,702,000. 75.70% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Oscar Health news, insider Mario Schlosser sold 395,000 shares of the firm’s stock in a transaction that occurred on Monday, September 22nd. The shares were sold at an average price of $18.43, for a total value of $7,279,850.00. Following the sale, the insider owned 501,148 shares in the company, valued at $9,236,157.64. This trade represents a 44.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 24.39% of the stock is owned by corporate insiders.

Oscar Health Stock Performance

NYSE OSCR opened at $21.03 on Friday. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $5.44 billion, a price-to-earnings ratio of -25.96 and a beta of 1.89. The firm’s 50 day simple moving average is $18.29 and its 200 day simple moving average is $16.05. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.80.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.90) by $0.01. The business had revenue of $2.86 billion for the quarter, compared to analyst estimates of $2.88 billion. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The firm’s revenue for the quarter was up 29.0% on a year-over-year basis. During the same quarter last year, the business posted $0.20 EPS. As a group, research analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Analyst Ratings Changes

OSCR has been the topic of several recent research reports. UBS Group reaffirmed a “sell” rating and set a $11.00 target price (down from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Oscar Health in a report on Wednesday, October 8th. Zacks Research raised shares of Oscar Health from a “strong sell” rating to a “hold” rating in a report on Monday. Wall Street Zen cut shares of Oscar Health from a “hold” rating to a “sell” rating in a report on Saturday, August 9th. Finally, Piper Sandler lowered their target price on shares of Oscar Health from $14.00 to $13.00 and set a “neutral” rating on the stock in a report on Thursday, August 14th. Six research analysts have rated the stock with a Hold rating and six have given a Sell rating to the stock. Based on data from MarketBeat, Oscar Health currently has an average rating of “Reduce” and a consensus target price of $13.19.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.